Prescribed by Hong Kong-registered Western medical doctors, we offer GLP-1 weight-loss pens and oral fat-blocking pills. Clinically proven to help you lose up to 22.5% of your body weight, our service is safe and confidential, with medication delivered to your door in as little as 4 hours.










GLP-1 agonists have been approved by the FDA and EMA for weight management, and their safety and efficacy have been demonstrated in large-scale clinical trials. Common side effects primarily include gastrointestinal reactions (such as nausea and diarrhea), which typically occur early in treatment and subside over time.
Mounjaro(tirzepatide)係 GLP-1 及 GIP 雙重受體激動劑,每週注射一次,臨床研究顯示最高可減重達 22.5%。其雙重作用機制,能更全面調節食慾同代謝,可能帶來更嘅減重效果。
Wegovy(semaglutide)係 GLP-1 單一受體激動劑,每週注射一次,減重可達 15%。作為全球最廣泛使用嘅減重針之一,超過 2000 萬人 已驗證其安全同有效性,累積咗最豐富嘅真實世界數據同長期使用經驗。
兩個產品都係每週一次注射,效果都非常出色,適合唔同需要嘅人選擇:想追求最高減重潛力嘅朋友,Mounjaro 嘅雙重機制或許更吸引;鍾意有最多人用過、最多數據支持嘅,就選 Wegovy。最終邊個適合你,建議咨詢醫生根據個人體質同目標決定。
We recommend using this product for at least 3–6 months to assess its effectiveness. Long-term use can help maintain weight loss results; after discontinuing use, you should combine the product with a healthy diet and exercise to prevent weight regain.
Injectable medications (GLP-1) reduce appetite by mimicking gut hormones and produce more significant weight loss (15–22.5%). Oral fat-blocking pills promote weight loss by inhibiting fat absorption; their effects are relatively mild (5–10%), but they are more convenient to use.
GLP-1 agonists naturally reduce appetite, so strict dieting is not necessary. However, combining them with a balanced diet and moderate exercise is recommended for optimal results. For fat-blocking pills, it is recommended to follow a low-fat diet to minimize gastrointestinal side effects.
Common side effects of GLP-1 agonists include nausea, diarrhea, and constipation, which typically occur early in treatment and gradually subside. Oil-absorbing tablets may cause oily stools. If you experience severe discomfort, contact your doctor immediately.